Legal Opinion
TorPharm, Inc. v. Thompson
District Court, District of Columbia
Decided April 25, 2003No. CIV.A. 03-0254(ESH)PublishedCited by 14 opinions
1Opinion of the Court
MEMORANDUM OPINION
HUVELLE, District Judge.
This is the latest installment in the long-running battle to determine which will be the first company permitted to market a generic version of the drug gabapentin. Competing for this privilege — and, more importantly, for the statutory right to sell the drug for 180 days free from generic competition — are plaintiff TorPharm, Inc. (“TorPharm”) and intervenor-defendant Purepac Pharmaceutical Co. (“Purepac”). Originally, the Food and Drug Administration (“FDA”) refused to approve Purepac’s application because it failed to include what the agency…
2Cases cited19 opinions
- United States v. Mead Corp.Supreme Court of the United States · 2001
- Bowman Transportation, Inc. v. Arkansas-Best Freight System, Inc.Supreme Court of the United States · 1975
- Butz v. Glover Livestock Commission Co.Supreme Court of the United States · 1973
- Eli Lilly & Co. v. Medtronic, Inc.Supreme Court of the United States · 1990
- Metropolitan Stevedore Co. v. RamboSupreme Court of the United States · 1997
14 more not listed; retrieve them via the Exa API.
3Cited by14 opinions
- Apotex, Inc. v. Food & Drug AdministrationCourt of Appeals for the D.C. Circuit · 2004
- Hi-Tech Pharmacal Co. v. United States Food & Drug AdministrationDistrict Court, District of Columbia · 2008
- Mylan Pharmaceuticals Inc. v. United States Food & Drug AdministrationDistrict Court, District of Columbia · 2011
- Bayer Schera Pharma AG v. Sandoz, Inc.District Court, S.D. New York · 2010
- Biovail Corp. v. U.S. Food & Drug AdministrationDistrict Court, District of Columbia · 2007
9 more not listed; retrieve them via the Exa API.